Cambridge biotech’s plan to merge with Trump commerce secretary’s SPAC falls apart

A Cambridge biotech’s plan to merge with a special-purpose acquisition company, or SPAC, sponsored by the former U.S. commerce secretary under President Donald Trump has fallen apart.